April 27, 2017 Licensing, IP, and Legal M&A, Partnerships Molecular Spectroscopy

JEOL RESONANCE and Mestrelab Research S.L., announce technology partnership for qNMR market – qNMR seamless

| | JEOL RESONANCE and Mestrelab Research S.L., announce technology partnership for qNMR market – qNMR seamless posted on April 27, 2017 fully automated signal acquisition and qNMR analysis capability ( read this press release… ) New Field Emission Cryo-Electron Microscope JEM-Z200FSC posted on April 27, 2017 automatically acquires image data for Single Particle Analysis... Read more

April 26, 2017 Licensing, IP, and Legal Life Science Tools

BD Licenses Novel Molecular Indexing Technology to Roche

FRANKLIN LAKES, N.J., Apr. 26, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to Roche for multiple commercial applications. BD’s patented stochastic labelling technology incorporating molecular indexes (known also as UMIs or molecular barcodes), enables the... Read more

April 20, 2017 Clinical Research/Diagn. Informatics & Software Licensing, IP, and Legal Life Science Tools

Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

March 31, 2017 Licensing, IP, and Legal Life Science Tools

Canopy Biosciences Licenses Novel Gene Editing Technology from Washington University and Johns Hopkins University

Technology gives researchers unprecedented control over gene expression NEWS PROVIDED BY Canopy Biosciences 31 Mar, 2017, 08:00 ET ST. LOUIS, March 31, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of products and services for gene editing and personalized medicine, announced today that it has entered an exclusive licensing agreement with Washington University in... Read more

March 20, 2017 Informatics & Software Licensing, IP, and Legal Life Science Tools

Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

March 7, 2017 Cell Analysis Tools Licensing, IP, and Legal

Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult “Ground-state” Stem Cell Technology

MINNEAPOLIS, Minnesota (March 7, 2017)- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating, and differentiating adult “ground-state” stem cells from healthy and diseased epithelial tissues. Working together, Bio-Techne and MCT will transition this breakthrough technology into... Read more